Search Login Register

gemcitabine Summary

3762 relevant articles (556 outcomes, 1723 trials/studies) found for this Drug

Description: structure given in first source; RN given refers to (D-erythro)-isomer

Also Known As: 2',2'-DFDC; 2',2'-difluoro-2'-deoxycytidine; 2',2'-difluorodeoxycytidine; 2'-deoxy-2',2''-difluorocytidine-5'-O-monophosphate; 2'-deoxy-2'-difluorocytidine Show All >>

Key Diseases for which gemcitabine is Relevant

  1. Pancreatic Neoplasms (Pancreatic Cancer) : 129 outcomes 299 studies in 792 results
  2. Neoplasms (Cancer) : 100 outcomes 321 studies in 1025 results
  3. Small Cell Carcinoma (Small Cell Lung Cancer) : 98 outcomes 463 studies in 831 results
  4. Breast Neoplasms (Breast Cancer) : 50 outcomes 147 studies in 270 results
  5. Carcinoma (Carcinomatosis) : 44 outcomes 160 studies in 417 results
Show All >>

Drugs Related to gemcitabine

  1. Cisplatin (Platino)
  2. Paclitaxel (Taxol)
  3. docetaxel (Taxotere)
  4. vinorelbine (Navelbine)
  5. Carboplatin (JM8)
  6. gemcitabine
  7. Fluorouracil (Carac)
  8. Platinum
  9. oxaliplatin (Eloxatin)
  10. irinotecan (Camptosar)
Show All >>

Therapies Related to gemcitabine

  1. Drug Therapy (Chemotherapy)
  2. Combination Drug Therapy (Combination Chemotherapy)
  3. Heterologous Transplantation (Xenotransplantation)
  4. Adjuvant Chemotherapy
  5. Palliative Care (Palliative Medicine)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.